Improving tumor infiltrating lymphocyte anti-cancer T cell therapies with small molecule ImmuneCell boosters

• Unité de recherche: INNOSUISSE
• Numéro de projet: 121.771 IP-LS
• Titre du projet anglais: Improving tumor infiltrating lymphocyte anti-cancer T cell therapies with small molecule ImmuneCell boosters

Mots-clé (Anglais)

Life sciences, Human medicine

Résumé des résultats (Abstract) (Anglais)

Tumour infiltrating lymphocytes (TIL) is a promising T cell-based immunotherapy against aggressive relapsing solid tumors. Lengthy manufacturing still limits its use. Our small-molecule boosters accelerate T cell growth and activation, and can decrease production time while also improving efficacy.